AHL
EW icon

Abel Hall LLC’s Edwards Lifesciences EW Stock Holding History

Abel Hall LLC’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,745
Closed -$220K – 1004
2026
Q1 		$220K Buy
+2,745
New +$226K 0.05% 571

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
TIM
Triodos Investment Management Driebergen-Rijsenburg, Netherlands $1.64B AUM 37.98% 1-Year Est. Return

Abel Hall LLC's EW Position: Q2 2026 in Review

Abel Hall LLC sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 2,745 shares — an estimated $220K sold.

Abel Hall LLC first reported a position in EW in Q1 2026 and held it in 1 quarter. The position peaked at $220K in Q1 2026. 501 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Abel Hall LLC reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • Abel Hall LLC sold 2,745 Edwards Lifesciences shares in Q2 2026, an estimated $220K.
  • Abel Hall LLC first reported a position in Edwards Lifesciences in Q1 2026 and held it in 1 quarter.
  • Abel Hall LLC's Edwards Lifesciences position peaked at $220K in Q1 2026.
  • 501 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.